Ann: Quarterly Investor Update, page-12

First 12 Last

Share
Profile

Follow
tradealot

1,900 Posts.

3203

08/02/19

19:58

Post #: 37381609
Share
Originally posted by soarus ↑

IR

$ISX’s transformation to a b2b neobank operating across the EU and Australia is almost complete!

It was a hectic quarter building out our various capabilities, including:

Finalising our transactional banking network in the EU, which now includes Visa, Mastercard, JCB, and shortly Diners, Discover, Amex and ChinaUnionPay,

deploying our core banking systems to the EU and Australia,

working through our final APRA, ASIC and RBA requirements for ADI licensing,

licensing Diners, Discover globally and ChinaUnionPay for EU and Australia,

integrating the Probanx team and products into ISXPay® and Paydentity™,

launching our IBAN issued and deposit taking capabilities in the EU,

connecting to 4300 other banks via SEPA network, and

making sure it all works as a seamless offering to our customers!

Sales and Operations were busy too – with new EMA customers and merchants for acquiring being contracted and prepared for onboarding.

Payment Services Directive 2
For those following the $ISX story for some time, the PSD2 is almost upon us. It was originally mooted to take effect in 2015, and will now finally become a requirement September 2018. That is, all card transactions will be subject to Strong Customer Authentication. Our proposition for SCA is much stronger than what it was in 2015, and we expect to be announcing a major partnership fairly soon to tackle the large gap between regulation and solutions in the market.

Expand

That IR post fills in the blanks from today's quarterly update. Thanks @soarus

The "Major Partnership" must have something to do with the European Banking Authority. https://eba.europa.eu/

This could be a huge cashcow by the sounds of it, especially using the wording "major partnership"

What an endorsement of isx's technology, partnering with a banking authority.

Cheers
Tradealot
ISX Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
9 Upvote

3 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 10 more messages in this thread...

First 12 Last

Add SP1 (ASX) to my watchlist

Ann: Quarterly Investor Update, page-12

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News